SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 21.40 |
| Enterprise Value ($M) | -6.30 |
| Book Value ($M) | 75.59 |
| Book Value / Share | 2.70 |
| Price / Book | 0.28 |
| NCAV ($M) | 63.94 |
| NCAV / Share | 2.28 |
| Price / NCAV | 0.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.72 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.07 |
| Current Ratio | 9.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 78.69 |
| Assets | 90.34 |
| Liabilities | 14.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Logos Global Management LP | |||
| 13G/A | Affinity Asset Advisors, LLC | 8.22 | 37.65 | |
| 13D/A | Orbimed Advisors Llc | 4.50 | -53.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,625 | 30,900 | 21.44 | |
| 1,307 | 9,503 | 13.75 | |
| 2,724 | 37,585 | 7.25 | |
| 6,917 | 30,513 | 22.67 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NMRA – Neumora Therapeutics, Inc. | NUVL – Nuvalent, Inc. |
| NVAX – Novavax, Inc. | OGI – Organigram Holdings Inc. |
| OLMA – Olema Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io